Shire gets FDA orphan drug designation for hemophilia A treatment 1 234 567

Shire gets FDA orphan drug designation for hemophilia A treatment

livecharts.co.uk

The US Food and Drug Administration has awarded orphan drug designation - which is intended to advance drug development for rare diseases - and investigational new drug status to Shire's gene therapy candidate SHP654 for the treatment of haemophilia A.

Full news

Share:

More:

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567